Harnessing Pathology of Pulmonary Hypertension to Therapeutic Advantage

All credits to Marlene Rabinovitch FPVRI, Professor of Pediatrics, at Stanford University School of Medicine, in Stanford- California | United States

Presented at the 1st Annual Drug Discovery and Development Symposium, July 14-15th 2014, Bethesda, USA

Additional key-words: endothelin receptor antagonists,BMPR2,PPARgamma,p53

About the author

Professor of Pediatrics

Stanford University

United States

Professor of Pediatrics

Stanford University

United States

Authors: Song M, Shen M, Zhou Y, Zheng K, Zhai Y, Xiao M, Wang X, Wang F, Sun X Source: Retina

Authors: Everett E, Mathioudakis N Source: Curr Diab Rep

Authors: Coelho da Mota DS, Sicuro FL, Resende AC, De Moura RS, Bottino DA, Bouskela E Source: J Surg Res

Authors: Sudheendran Swayamprabha S, Kumar Dubey D, Song WC, Lin YT, Ashok Kumar Yadav R, Singh M, Jou JH Source: Materials (Basel)

Authors: Kimura D, Kobayashi T, Maruyama E, Oosuka S, Kohmoto R, Fukumoto M, Sato T, Kida T, Ikeda T Source: Medicine (Baltimore)

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI